comparemela.com

Latest Breaking News On - Cuvid - Page 1 : comparemela.com

Therma Bright Inc : Therma Bright Provides Progress Update on FDA EUA & Health Canada Interim Order Applications for Its AcuVid COVID-19 Rapid Antigen Saliva Test

Toronto, Ontario (Newsfile Corp. - August 4, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test

United statesNewsfile corpTherma bright incHealth canadaRegulation services providerVenture exchangeAntigen saliva testIts acuvidAntigen salivaBridge globalInterim orderRob fiaEastern europe

Therma Bright Inc : Therma Bright Submits Health Canada Application for Its AcuVid COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)

Toronto, Ontario (Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test

United statesTherma bright incNewsfile corpCompany us foodAcuvid health canadaHealth canadaDrug administration emergency use authorizationRegulation services providerVenture exchangeAntigen saliva testPoint of care useDrug administrationEmergency use authorizationRob fiaUse authorization

Therma Bright Inc : Therma Bright Provides Update on FDA EUA Application Process For AcuVid COVID-19 Rapid Antigen Saliva Test

Toronto, Ontario (Newsfile Corp. - June 2, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive

United statesWorld health organizationTherma bright incCompany acuvidProduct developmentNewsfile corpWashington postHealth canadaDrug administration emergency use authorizationVenture exchangeRegulation services providerAntigen saliva testDrug administrationEmergency use authorizationTherma brightPositive percent agreement

Therma Bright Inc : Therma Bright AcuVid COVID-19 Rapid Antigen Saliva Test s Antibodies Successfully Detect the COVID-19 Omicron B 1 1 529 Variant

Toronto, Ontario (Newsfile Corp. - December 16, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test and other

United statesUnited kingdomSouth africaDrug administration for emergency use authorizationDrug administration staffWorld health organizationDuring the public health emergencyTherma bright incGuidance for developersNewsfile corpVenture exchangeRegulation services providerAntigen saliva testEastern europeanTherma brightRob fia

vimarsana © 2020. All Rights Reserved.